An analysis of more than five years of Medicare Part D and Medicaid prescription data found that after states legalized weed, the number of opioid prescriptions and the daily dose of opioids went way down.
Production of injectable opioids has nearly ground to a halt due to manufacturing problems, creating a shortage of staple medications used to treat a wide array of patients.
The sole influenza vaccine made in cell culture in the United States may have worked about 20 percent better this flu season than the standard vaccines made in eggs, Food and Drug Administration Commissioner Scott Gottlieb said Thursday.
The Centers for Disease Control and Prevention is asking Congress for money for a new building to house the laboratories that work on the deadliest pathogens known to humankind.
It’s too soon to say the flu season has peaked, but it’s at least possible it may have plateaued.
Late last year Oxitec debuted its first “mobile production unit” — a miniature factory designed to help expand its reach.
The official U.S. Olympic Committee’s Sports Medicine Division recruits a crew of volunteer doctors — as well as orthopedists, chiropractors, nurses, sports therapists, massage therapists, and more — every two years.
Dozens of doctors, medical ethicists, and lawyers are warning Congress that legislation to allow Americans with life-threatening conditions access to unapproved, experimental drugs risks harming patients’ health.
A government shutdown of the FDA, CDC and NIH will likely have widespread and long-lasting consequences for public health.
Luxturna, a gene therapy with a list price $850,000, is the latest flashpoint in the debate over how to afford innovative medicines.
